118 related articles for article (PubMed ID: 17233116)
1. Electrogene therapy with p53 of murine sarcomas alone or combined with electrochemotherapy using cisplatin.
Grosel A; Sersa G; Kranjc S; Cemazar M
DNA Cell Biol; 2006 Dec; 25(12):674-83. PubMed ID: 17233116
[TBL] [Abstract][Full Text] [Related]
2. Effects of electrogenetherapy with p53wt combined with cisplatin on curvival of human tumor cell lines with different p53 status.
Cemazar M; Grosel A; Glavac D; Kotnik V; Skobrne M; Kranjc S; Mir LM; Andre F; Opolon P; Sersa G
DNA Cell Biol; 2003 Dec; 22(12):765-75. PubMed ID: 14683587
[TBL] [Abstract][Full Text] [Related]
3. Cancer electrogene therapy with interleukin-12.
Cemazar M; Jarm T; Sersa G
Curr Gene Ther; 2010 Aug; 10(4):300-11. PubMed ID: 20560875
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitizing effect of electrochemotherapy in a fractionated radiation regimen in radiosensitive murine sarcoma and radioresistant adenocarcinoma tumor model.
Kranjc S; Tevz G; Kamensek U; Vidic S; Cemazar M; Sersa G
Radiat Res; 2009 Dec; 172(6):677-85. PubMed ID: 19929414
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content.
Cemazar M; Milacic R; Miklavcic D; Dolzan V; Sersa G
Anticancer Drugs; 1998 Jul; 9(6):525-30. PubMed ID: 9877240
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.
Miyake H; Yamanaka K; Muramaki M; Hara I; Gleave ME
Neoplasia; 2005 Feb; 7(2):171-9. PubMed ID: 15802022
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity.
Sedlar A; Dolinsek T; Markelc B; Prosen L; Kranjc S; Bosnjak M; Blagus T; Cemazar M; Sersa G
Radiol Oncol; 2012 Dec; 46(4):302-11. PubMed ID: 23412658
[TBL] [Abstract][Full Text] [Related]
8. Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors.
Sersa G; Kranjc S; Cemazar M
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):1037-41. PubMed ID: 10705027
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo experiments on electrochemotherapy for bladder cancer.
Vásquez JL; Ibsen P; Lindberg H; Gehl J
J Urol; 2015 Mar; 193(3):1009-15. PubMed ID: 25245485
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity.
Milas M; Yu D; Lang A; Ge T; Feig B; El-Naggar AK; Pollock RE
Cancer Gene Ther; 2000 Mar; 7(3):422-9. PubMed ID: 10766348
[TBL] [Abstract][Full Text] [Related]
11. Electroporation of LPB sarcoma cells in vitro and tumors in vivo increases the radiosensitizing effect of cisplatin.
Kranjc S; Cemazar M; Grosel A; Scancar J; Sersa G
Anticancer Res; 2003; 23(1A):275-81. PubMed ID: 12680224
[TBL] [Abstract][Full Text] [Related]
12. Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model.
Cemazar M; Miklavcic D; Mir LM; Belehradek J; Bonnay M; Fourcault D; Sersa G
Eur J Cancer; 2001 Jun; 37(9):1166-72. PubMed ID: 11378348
[TBL] [Abstract][Full Text] [Related]
13. Effective treatment of perianal tumors in dogs with electrochemotherapy.
Tozon N; Kodre V; Sersa G; Cemazar M
Anticancer Res; 2005; 25(2A):839-45. PubMed ID: 15868917
[TBL] [Abstract][Full Text] [Related]
14. Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin.
Cemazar M; Miklavcic D; Scancar J; Dolzan V; Golouh R; Sersa G
Br J Cancer; 1999 Mar; 79(9-10):1386-91. PubMed ID: 10188880
[TBL] [Abstract][Full Text] [Related]
15. Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats.
Tozon N; Sersa G; Cemazar M
Anticancer Res; 2001; 21(4A):2483-8. PubMed ID: 11724311
[TBL] [Abstract][Full Text] [Related]
16. Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine.
Deharvengt S; Rejiba S; Wack S; Aprahamian M; Hajri A
Int J Oncol; 2007 Jun; 30(6):1397-406. PubMed ID: 17487360
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
[TBL] [Abstract][Full Text] [Related]
18. Metastatic potential of melanoma cells is not affected by electrochemotherapy.
Todorovic V; Sersa G; Mlakar V; Glavac D; Flisar K; Cemazar M
Melanoma Res; 2011 Jun; 21(3):196-205. PubMed ID: 20216102
[TBL] [Abstract][Full Text] [Related]
19. Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas.
Tevz G; Kranjc S; Cemazar M; Kamensek U; Coer A; Krzan M; Vidic S; Pavlin D; Sersa G
J Gene Med; 2009 Dec; 11(12):1125-37. PubMed ID: 19777440
[TBL] [Abstract][Full Text] [Related]
20. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients.
Sersa G; Stabuc B; Cemazar M; Miklavcic D; Rudolf Z
Clin Cancer Res; 2000 Mar; 6(3):863-7. PubMed ID: 10741708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
